Comparative Pharmacology
Head-to-head clinical analysis: AMINOSYN 10 versus AMINOSYN PF 10.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMINOSYN 10 versus AMINOSYN PF 10.
AMINOSYN 10% vs AMINOSYN-PF 10%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aminosyn 10% provides a mixture of essential and non-essential amino acids to support protein synthesis and maintain nitrogen balance in patients unable to tolerate adequate oral or enteral nutrition. Each amino acid serves as a substrate for protein synthesis, hormone production, and other metabolic processes.
Aminosyn-PF 10% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis and nitrogen balance in neonates and pediatric patients.
Intravenous infusion: 1-1.5 g/kg/day (as amino acids), typically 500 mL of 10% solution (50 g amino acids) over 8-12 hours daily.
Intravenous infusion: 1-1.5 g amino acids/kg/day (protein equivalent) as part of total parenteral nutrition. Typical rate: 0.5-2.0 mL/kg/hour initially, titrated to metabolic needs.
None Documented
None Documented
Amino acids: 0.5-1 hour for free amino acids; terminal half-life of infused nitrogen is approximately 2-4 hours; clinical context: reflects rapid uptake and metabolism.
Variable; amino acids have half-lives of minutes to hours; clinical context: continuous infusion maintains steady state
Renal (primarily as amino acids and metabolites); ~90% of infused amino nitrogen is excreted renally within 24-48 hours; <5% biliary/fecal.
Renal: >90% as amino acids and metabolites; <10% fecal/biliary
Category C
Category C
Parenteral Nutrition Solution
Parenteral Nutrition Solution